Professor John Hughes BSc MA PhD DMed DSc FBPS FRS

Emeritus Fellow

  • Former Director, Parke-Davis Neuroscience Research Centre
  • Honorary Professor of Neuropharmacology, CU Dept of Pharmacology

John Hughes has been a Fellow of Wolfson since 1983.

Following BSc and PhD degrees from Kings College, London, John took a Research Fellowship at Yale University Medical School before being appointed Lecturer in Pharmacology at Aberdeen University. He then returned to London as Reader in Pharmacological Biochemistry at Imperial College, where he later became Professor. In Cambridge, he has been Director of the Parke-Davis Neuroscience Centre.

John Hughes’ academic and research interests are in the fields of drug abuse, molecular neurobiology and opioid peptides. He has been Vice-President of Research for the Warner-Lambert/Parke-Davis Company, Chairman of Cambridge Biotechnology Limited, Chairman of the Scientific Advisory Board of Synaptica Limited, a member of the Substance Abuse Committee of the Mental Health Foundation and Chairman of the Research Committee of the Chronic Fatigue Syndrome Research Foundation.

John has edited a number of scientific and medical journals, and his own publications include Centrally Acting Peptides (1978), Opioids Past, present and Future (1984), The Neuropeptide Cholecystokinin (CCK) (1989), and articles in Nature, British Journal of Pharmacology and Brain Research. He has received a number of academic and research awards, and was appointed FRS in 1993.

Outside the laboratory, John’s interests include golf and gardening.